铁螯合剂1,2 - 二烷基 - 3 - 羟基吡啶 - 4 - 酮对小鼠肝脏脂质过氧化和谷胱甘肽水平的影响。 - Suppr

Suppr

超能文献

Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.

作者信息

Eybl V, Caisová D, Koutenský J, Kontoghiorghes G J

机构信息

Dept. of Pharmacology, Medical Faculty Charles University, Pilsen, CSFR.

出版信息

Arch Toxicol Suppl. 1991;14:185-7. doi: 10.1007/978-3-642-74936-0_37.

DOI:10.1007/978-3-642-74936-0_37

PMID:1805729

Abstract

摘要

相似文献

Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.铁螯合剂1,2 - 二烷基 - 3 - 羟基吡啶 - 4 - 酮对小鼠肝脏脂质过氧化和谷胱甘肽水平的影响。

Arch Toxicol Suppl. 1991;14:185-7. doi: 10.1007/978-3-642-74936-0_37.

Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.铁载体绿脓菌素和羟基吡啶-4-酮在铁负荷肝细胞培养物中的抗氧化和自由基清除活性：将它们的保护机制与去铁胺的保护机制进行比较

Free Radic Biol Med. 1992 Nov;13(5):499-508. doi: 10.1016/0891-5849(92)90144-6.

The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice.去铁酮（L1）和去铁胺对饮食性铁负荷小鼠体内铁及必需元素组织水平和氧化状态参数的影响。

Toxicol Lett. 2002 Mar 10;128(1-3):169-75. doi: 10.1016/s0378-4274(01)00541-0.

Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.

Blood. 1991 May 1;77(9):2049-53.

Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.羟基吡啶-4-酮CP20和CP94对大鼠和人肝细胞培养中铁毒性的抑制作用

J Hepatol. 1995 Aug;23(2):166-73. doi: 10.1016/0168-8278(95)80331-9.

Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.3-羟基吡啶-4-酮口服螯合剂动员的铁的来源与去向：通过网状内皮细胞和肝细胞铁储存的选择性放射性铁探针在多次输血大鼠中的研究

Blood. 1992 Jan 1;79(1):248-53.

Glutathione depletion increases nitric oxide-induced oxidative stress in primary rat hepatocyte cultures: involvement of low-molecular-weight iron.谷胱甘肽耗竭增加原代大鼠肝细胞培养物中一氧化氮诱导的氧化应激：低分子量铁的参与。

Free Radic Biol Med. 2003 May 15;34(10):1283-94. doi: 10.1016/s0891-5849(03)00108-4.

The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.铁螯合剂去铁胺可防止顺铂诱导的大鼠肾皮质切片中的脂质过氧化。

Jpn J Pharmacol. 1991 Oct;57(2):259-62. doi: 10.1254/jjp.57.259.

The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.

J Pharmacol Exp Ther. 1994 May;269(2):632-6.

EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.铁负载肝细胞培养中绿脓菌素和羟基吡啶-4-酮铁螯合剂抗氧化活性的电子顺磁共振研究：与去铁胺的比较

Free Radic Biol Med. 1995 Feb;18(2):303-10. doi: 10.1016/0891-5849(94)e0144-8.

引用本文的文献

New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine.铁螯合/抗氧化药物在医学中用于自由基病理疾病的重新利用的新方法和策略。

Antioxidants (Basel). 2025 Aug 10;14(8):982. doi: 10.3390/antiox14080982.

Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone.地拉罗司及其金属配合物在氧化损伤模型系统中的抗氧化活性：与去铁酮的比较。

Molecules. 2021 Aug 20;26(16):5064. doi: 10.3390/molecules26165064.

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.铁与螯合作用在生物化学和医学中的应用：控制铁代谢和治疗相关疾病的新方法。

Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456.

Characterization of the neuroprotective potential of derivatives of the iron chelating drug deferiprone.铁螯合剂去铁酮衍生物的神经保护潜力特征

Neurochem Res. 2015 Mar;40(3):609-20. doi: 10.1007/s11064-014-1508-7. Epub 2015 Jan 6.

Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.去铁酮治疗地中海贫血及其他病症铁过载的获益与风险：与去铁胺的流行病学及治疗学方面比较

Drug Saf. 2003;26(8):553-84. doi: 10.2165/00002018-200326080-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验